» Articles » PMID: 18591247

Glucose Activates ChREBP by Increasing Its Rate of Nuclear Entry and Relieving Repression of Its Transcriptional Activity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2008 Jul 2
PMID 18591247
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Carbohydrate response element-binding protein (ChREBP) is a glucose-responsive transcription factor that activates genes involved in de novo lipogenesis in mammals. The current model for glucose activation of ChREBP proposes that increased glucose metabolism triggers a cytoplasmic to nuclear translocation of ChREBP that is critical for activation. However, we find that ChREBP actively shuttles between the cytoplasm and nucleus in both low and high glucose in the glucose-sensitive beta cell-derived line, 832/13. Glucose stimulates a 3-fold increase in the rate of ChREBP nuclear entry, but trapping ChREBP in the nucleus by mutagenesis or with a nuclear export inhibitor does not lead to constitutive activation. In fact, mutational studies targeting the nuclear export signal of ChREBP also identified a distinct function essential for glucose-dependent transcriptional activation. From this, we conclude that an additional event independent of nuclear translocation is required for activation. The N-terminal segment of ChREBP (amino acids 1-298) has previously been shown to repress activity under basal conditions. This segment has five highly conserved regions, Mondo conserved regions 1-5 (MCR1 to -5). Based on activating mutations in MCR2 and MCR5, we propose that these two regions act coordinately to repress ChREBP in low glucose. In addition, other mutations in MCR2 and mutations in MCR3 were found to prevent glucose activation. Hence, we conclude that both relief of repression and adoption of an activating form are required for ChREBP activation.

Citing Articles

Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives.

Yang Y, Wen R, Yang N, Zhang T, Liu C Mol Med. 2023; 29(1):93.

PMID: 37415097 PMC: 10327358. DOI: 10.1186/s10020-023-00684-9.


Regulation of Liver Glucose and Lipid Metabolism by Transcriptional Factors and Coactivators.

Ramatchandirin B, Pearah A, He L Life (Basel). 2023; 13(2).

PMID: 36836874 PMC: 9962321. DOI: 10.3390/life13020515.


TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients.

Borowiec A, Wlaszczuk A, Olakowska E, Lewin-Kowalik J Med Pharm Rep. 2022; 95(3):243-250.

PMID: 36060506 PMC: 9387585. DOI: 10.15386/mpr-2187.


Maladaptive positive feedback production of ChREBPβ underlies glucotoxic β-cell failure.

Katz L, Brill G, Zhang P, Kumar A, Baumel-Alterzon S, Honig L Nat Commun. 2022; 13(1):4423.

PMID: 35908073 PMC: 9339008. DOI: 10.1038/s41467-022-32162-x.


The polyol pathway is an evolutionarily conserved system for sensing glucose uptake.

Sano H, Nakamura A, Yamane M, Niwa H, Nishimura T, Araki K PLoS Biol. 2022; 20(6):e3001678.

PMID: 35687590 PMC: 9223304. DOI: 10.1371/journal.pbio.3001678.


References
1.
Yamashita H, Takenoshita M, Sakurai M, Bruick R, Henzel W, Shillinglaw W . A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A. 2001; 98(16):9116-21. PMC: 55382. DOI: 10.1073/pnas.161284298. View

2.
Dentin R, Girard J, Postic C . Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie. 2005; 87(1):81-6. DOI: 10.1016/j.biochi.2004.11.008. View

3.
Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K . Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A. 2001; 98(24):13710-5. PMC: 61106. DOI: 10.1073/pnas.231370798. View

4.
Iizuka K, Miller B, Uyeda K . Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol Endocrinol Metab. 2006; 291(2):E358-64. DOI: 10.1152/ajpendo.00027.2006. View

5.
Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck J . Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes. 2006; 55(8):2159-70. DOI: 10.2337/db06-0200. View